Pfizer-BioNTech vaccine can produce antibodies, immune cells 12 days after first dose: S'pore study


The first dose of the Pfizer-BioNTech vaccine was found to be 85 per cent effective against Covid-19.- ST

SINGAPORE (The Straits Times/ANN): Researchers here have found that the Pfizer-BioNTech vaccine can help the body to produce specific types of antibodies and immune cells against the SARS-CoV-2 virus, which may explain why it is able to offer protection from Covid-19 as early as 12 days after a single dose.

According to an Israeli study conducted among healthcare workers, the first dose of the Pfizer-BioNTech vaccine was found to be 85 per cent effective against Covid-19.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Singapore , Pfizer-BioNtech , vaccine , antibodies , study

   

Next In Aseanplus News

Japan launches fifth round of Fukushima treated water discharge
Olympics-Games' broadcaster embracing AI but remains wary of deepfakes
Malaysia closely monitoring situation in West Asia, reiterates call for all parties to exercise restraint
Four dead in UAE, Dubai airport still disrupted after storm
Olympics-McKeown breaks Australian all-comers record in 50 metres backstroke
Asean News Headlines at 10pm on Friday (April 19, 2024)
Drunk driving, crashing into police barricade lands Thai minister’s son in jail for four months
Seven people killed in Jakarta's Mampang Prabatan blaze
World No.1 and crowd favourite Viktor Axelsen headlines list of big guns vying for Singapore Badminton Open
Actress Shu Qi gets lavish surprise birthday bash from husband Stephen Fung

Others Also Read